Document is current
Any future updates will be listed below
-
Authors
Kollmannsberger, Christian
Britten, Carolyn D.
Olszanski, Anthony J.
Walker, Joan Andrews
Zang, Wei
Willard, Melinda D.
Radtke, David B.
Farrington, Daphne L.
Bell-McGuinn, Katherine M.
Patnaik, Amita
- License Information
-
More Information
Article History
Received: 18 January 2021
Accepted: 24 June 2021
First Online: 15 July 2021
Declarations
:
: Study was conducted in accordance with the International Conference on Harmonisation Good Clinical Practice E6 guidelines, and ethics guidelines that include the Declaration of Helsinki and Council for International Organizations of Medical Sciences. The protocol was approved by the Institutional Review Boards before patient recruitment.
: Written informed consent was obtained from all individual participants included in the study.
: CK reports being an ad hoc advisory board member for BMS, Merck, Pfizer, Eisai, Ipsen, Astellas, Janssen, Bayer and receiving speaker honoraria from Pfizer, Ipsen, BMS, Merck. CDB reports receiving research grants from Eli Lilly and Company, AstraZeneca, Celgene, EMD Serono, FivePrime, Genentech, Incyte, Merck, Millennium, Novartis, Regeneron, and Tesaro; being a paid consultant for Five Prime and Pfizer; receiving travel grants from Amgen, Five Prime, and Pfizer; and is an employee and shareholder of Amgen. AJO reports being a paid consultant for Merck, BMS, and Array and a paid instructor for Pfizer. JAW is a former employee of Eli Lilly and Company and a shareholder of Eli Lilly and Company, Pfizer, and Johnson & Johnson. MDW, WZ, and DBR are employees and shareholders of Eli Lilly and Company. DLF is a former employee of Eli Lilly and Company and Verastem Oncology, a current employee of Editas Medicine; and a shareholder of Eli Lilly and Company, Verastem Oncology, and Editas Medicine. KMBM is a former employee of Eli Lilly and Company, a current employee of AbbVie and a shareholder of Eli Lilly and Company. AP reports receiving research grants from Merck, Pfizer, Eli Lilly and Company, Plexxikon, Corvus Pharmaceuticals, Tesaro, Abbvie, Forty Seven, Five Prime Therapeutics, Infinity Pharmaceuticals, Pieris Pharmaceuticals, Surface Oncology, Livzon, Vigeo Therapeutics, Astellas Pharma, Klus Pharma, Symphogen, Syndax, Arcus, Fochon, Upsher-Smith, Exelixis, Innovent Biologics (Suzhou), Seattle Genetics.
